FDA Approves First Generic Tulathromycin for Cattle & Swine
USAgNet - 02/22/2021
The FDA has approved the first two generic tulathromycin injectable products for the treatment and control of certain diseases in both cattle and swine.
Both generic products, Macrosyn and Increxxa, are approved for indications such as the treatment of bovine respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis in beef and non-lactating dairy cattle, suckling calves, dairy calves and veal calves.
It also helps control of respiratory disease in beef and non-lactating dairy cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis.
- Pilgrim's Pride Pleads Guilty to Price Fixing
- Senate Confirms Vilsack Appointment, Bernie Votes No
- Commodity Classic Launches Podcast on Farm Stress, Mental Health
- Still Time to Be Counted in Local Food Marketing Survey
- Goodyear Acquires Rival Tire Maker Cooper
- EPA Supports Court's RFA Decision
- Vilsack Confirmation Hearing Set for Tuesday